See also this year's filing and all EDGAR filings for this company.
PDF Report 0001178670_2026_Alnylam_Pharmaceuticals_INC.pdf
Logs
Graph
Absolute values for 0001178670, Alnylam Pharmaceuticals INC
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 4,050,662,000 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 0 |
| 2 | PropertyPlantAndEquipmentNet | 513,147,000 |
| 3 | remainder_Assets | 402,522,000 |
| 4 | LiabilitiesCurrent | 1,466,349,000 |
| 5 | LiabilitiesNoncurrent | 232,681,000 |
| 6 | remainder_Liabilities | 2,478,125,000 |
| 7 | CostOfGoodsAndServicesSold | 2,519,013,773 |
| 8 | SellingGeneralAndAdministrativeExpense | 2,013,559,671 |
| 9 | ResearchAndDevelopmentExpense | 1,353,818,187 |
| 10 | remainder_Expenses | -26,243,082 |
| 11 | remainder_Revenues | 11,024,827,518 |
| 12 | remainder_NetIncome | -181,428,044 |
| 13 | remainder_ComprehensiveNetIncome | 5,428,212 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 4,966,331,000 |
| 1 | Liabilities | 4,177,155,000 |
| 2 | Expenses | 5,860,148,549 |
| 3 | Revenues | 11,024,827,518 |
| 4 | StockholdersEquity | 789,176,000 |
| 5 | NetIncome | 4,983,250,925 |
| 6 | ComprehensiveNetIncome | 4,985,965,031 |
| 7 | BaseVar | 13,107,659,162 |
| 8 | EconomicCapitalRatiobeforeLimitedLiability | 1.47 |
| 9 | EconomicCapitalRatio | 2.65 |
Edgar->Model Mapping
Feature Distribution
Change over Time
